Calidi Biotherapeutics, Inc. (CLDI) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2025-12-17

Calidi Biotherapeutics, Inc. (CLDI) — no SEC Form 4 insider filings recorded in the last 90 days. 5 Form 8-K material event filings were reported by CLDI in the last 90 days. InsiderAlpha tracks every CLDI SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Calidi Biotherapeutics, Inc. (CLDI)

SEC CIK	0001855485

90-Day SEC Filing Activity

Form 8-K filings (90d)	5
Latest Form 4 filing	2025-12-17

Recent CLDI Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2025-12-12	Camaisa Allan	Director	S — Open-market sale	850	$1.46	$1K	SEC
2025-12-12	Camaisa Allan	Director	S — Open-market sale	850	$1.46	$1K	SEC
2025-08-21	Jackson Andrew C.	Chief Financial Officer	P — Open-market purchase	2.5K	$2.00	$5K	SEC
2025-08-21	Poma Eric E	Chief Executive Officer	P — Open-market purchase	25.0K	$2.00	$50K	SEC
2025-08-21	Leftwich Scott	Director	P — Open-market purchase	125.0K	$2.00	$250K	SEC
2025-08-21	Schoeneck James A	Director	P — Open-market purchase	75.0K	$2.00	$150K	SEC
2024-12-17	Camaisa Allan	CEO and Chairman of the Board	S — Open-market sale	10.0K	$1.62	$16K	SEC

All transactions sourced from SEC EDGAR Form 4 filings for Calidi Biotherapeutics, Inc. (CLDI). Updated in real time as new filings are submitted to the SEC.

Recent CLDI Form 8-K Material Events

2026-06-23 — Item 5.02, 7.01, 8.01, 9.01 [SEC]
2026-06-18 — Item 5.07 [SEC]
2026-05-29 — Item 1.01, 3.02, 9.01 [SEC]
2026-05-14 — Item 2.02, 7.01, 9.01 [SEC]
2026-05-08 — Item 1.01, 3.02, 9.01 [SEC]

Recent Insider Filings

2025-12-17 — Camaisa Allan (Director)
2025-12-16 — Camaisa Allan (Director)
2025-09-03 — Poma Eric E (Chief Executive Officer)
2025-09-03 — Jackson Andrew C. (Chief Financial Officer)
2025-09-03 — Fernandez Santidrian Antonio (Chief Scientific Officer)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in CLDI insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

CLDI Insider Trading — FAQ

What is the latest insider trade for CLDI?: Calidi Biotherapeutics, Inc. (CLDI) had 0 insider filings in the last 90 days, with the most recent on 2025-12-17. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying CLDI stock?: 0 insider purchases of CLDI were filed in the last 90 days.
How many insiders are selling CLDI stock?: 0 insider sales of CLDI were filed in the last 90 days.
Where can I see CLDI SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every CLDI SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live CLDI dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.